1. FDA draft guidance on benefit-risk assessments for NDAs and BLAs

   News item 09 October 2021 Pages: 1 - 1

2. Gadolinium-based contrast: risk of congenital abnormalities, stillbirth?

   News item 09 October 2021 Pages: 2 - 2

3. No association between COVID-19 vaccination and menstrual disorders

   News item 09 October 2021 Pages: 3 - 3

4. PURE75 gel sanitiser recall in Canada due to methanol-related health risks

   News item 09 October 2021 Pages: 4 - 4

5. Recommendations for paracetamol use during pregnancy

   News item 09 October 2021 Pages: 5 - 5

6. Acute kidney injury or mortality with hydroxyethyl starch

   Clinical study 09 October 2021 Pages: 6 - 6

7. Deaths associated with cough and cold medication in children

   Clinical study 09 October 2021 Pages: 7 - 7

8. FAERS reports involving anti-obesity medications

   Clinical study 09 October 2021 Pages: 8 - 8

9. Menopausal hormonal replacements in the UK: little risk of dementia

   Clinical study 09 October 2021 Pages: 9 - 9

10. Safety of combination therapy in Staphylococcus aureus bacteraemia

    Clinical study 09 October 2021 Pages: 10 - 10

11. Severe GI manifestations of DRESS syndrome underrecognised

    Clinical study 09 October 2021 Pages: 11 - 11

12. Statin-related adverse events in Latin America

    Clinical study 09 October 2021 Pages: 12 - 12

13. Other adverse reaction research

    News item 09 October 2021 Pages: 13 - 13

14. 4-aminomethylbenzoic-acid/batroxobin

    Case report 09 October 2021 Pages: 14 - 14

15. Acetazolamide

    Case report 09 October 2021 Pages: 15 - 15

16. Aciclovir/dexamethasone/famciclovir

    Case report 09 October 2021 Pages: 16 - 16

17. Adalimumab

    Case report 09 October 2021 Pages: 17 - 17

18. Adalimumab

    Case report 09 October 2021 Pages: 18 - 18

19. Adalimumab/certolizumab pegol

    Case report 09 October 2021 Pages: 19 - 19

20. Alcohol

    Case report 09 October 2021 Pages: 20 - 20

21. Alectinib/ceritinib/crizotinib

    Case report 09 October 2021 Pages: 21 - 21

22. Alectinib/crizotinib

    Case report 09 October 2021 Pages: 22 - 22

23. Alemtuzumab

    Case report 09 October 2021 Pages: 23 - 23

24. Alglucosidase-α

    Case report 09 October 2021 Pages: 24 - 24

25. Alirocumab/evolocumab

    Case report 09 October 2021 Pages: 25 - 25

26. Amikacin/cefepime

    Case report 09 October 2021 Pages: 26 - 26

27. Amiodarone

    Case report 09 October 2021 Pages: 27 - 27

28. Amiodarone/metoprolol

    Case report 09 October 2021 Pages: 28 - 28

29. Amiodarone/prednisolone

    Case report 09 October 2021 Pages: 29 - 29

30. Amlodipine/norepinephrine

    Case report 09 October 2021 Pages: 30 - 30

31. Amoxicillin/clavulanic-acid

    Case report 09 October 2021 Pages: 31 - 31

32. Amphotericin-B-liposomal

    Case report 09 October 2021 Pages: 32 - 32

33. Anakinra/dexamethasone

    Case report 09 October 2021 Pages: 33 - 33

34. Anidulafungin/corticosteroids/piperacillin/tazobactum

    Case report 09 October 2021 Pages: 34 - 34

35. Anti-digoxin-polyclonal-antibody/atropine/isoprenaline

    Case report 09 October 2021 Pages: 35 - 35

36. Antiarrhythmics/potassium

    Case report 09 October 2021 Pages: 36 - 36

37. Antibacterials

    Case report 09 October 2021 Pages: 37 - 37

38. Antibacterials

    Case report 09 October 2021 Pages: 38 - 38

39. Antibacterials

    Case report 09 October 2021 Pages: 39 - 39

40. Antibacterials/antiepileptic drugs/ naloxone

    Case report 09 October 2021 Pages: 40 - 40

41. Antibacterials/antivirals

    Case report 09 October 2021 Pages: 41 - 41

42. Antihyperglycaemics/digoxin/levothyroxine-sodium

    Case report 09 October 2021 Pages: 42 - 42

43. Antineoplastics

    Case report 09 October 2021 Pages: 43 - 43

44. Antineoplastics

    Case report 09 October 2021 Pages: 44 - 44

45. Antineoplastics

    Case report 09 October 2021 Pages: 45 - 45

46. Antineoplastics

    Case report 09 October 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 09 October 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 09 October 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 09 October 2021 Pages: 49 - 49

50. Antineoplastics

    Case report 09 October 2021 Pages: 50 - 50